Clinical Outcomes in Donor-Specific Antibody–Negative Flow Cytometry Crossmatch–Positive Transplant Recipients: A Systematic Review
Muhammed Zubair, Naema Liaqat, Kulsoom Muhammad Ilyas Khan, Ahmad M I Fayyad & Sara M I Fayyad · Asian Journal of Advanced Research and Reports · 2026
Background: Although it is true that donor-specific antibody (DSA) positivity is a highly validated risk factor of rejection and graft loss, it is not clear that a positive flow cytometry crossmatch (FCXM) without detectable DSA does have clinical implications. This is a valuable...
Open access
Research Article
10.9734/ajarr/2026/v20i61388